Premarket Mover: G1 Therapeutics Inc (GTHX) Up 1.88%

G1 Therapeutics Inc (GTHX) has gained Monday morning, with the stock increasing 1.88% in pre-market trading to 3.8. GTHX's short-term technical score of 70 indicates that the stock has traded more bullishly over the last month than 70% of stocks on the market. In the Biotechnology industry, which ranks 86 out of 146 industries, GTHX ranks higher than 77% of stocks. G1 Therapeutics Inc has fallen 11.40% over the past month, closing at $4.40 on February 5. During this period of time, the stock fell as low as $2.10 and as high as $5.00. GTHX has an average analyst recommendation of Buy. The company has an average price target of $8.50.

GTHX has an Overall Score of 84. Find out what this means to you and get the rest of the rankings on GTHX!

See Full GTHX Report

G1 Therapeutics Inc has a Long-Term Technical rank of 87. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 13% of the market scoring higher. In the Biotechnology industry which is number 44 by this metric, GTHX ranks better than 44% of stocks.

Important Dates for Investors in GTHX:

-G1 Therapeutics Inc is set to release earnings on 2024-05-28. Over the last 12 months, the company has reported EPS of $-1.47. -We do not have a set dividend date for G1 Therapeutics Inc at this time. Click Here To Get The Full Report on G1 Therapeutics Inc (GTHX)